Largest ever Parkinson’s research trial is starting now
Date
Research news
Date
A new research trial will start by testing 2 potential treatments that could slow or even stop Parkinson’s getting worse.
Date
HER-096, a potential new Parkinson's treatment, has shown promising phase 1 trial results, proving it’s safe, well-tolerated, and effective in reaching the brain in people with Parkinson's. This is a crucial step towards a drug that could slow, stop, or even repair Parkinson's damage.
Date
As the leading funder of Parkinson’s research in Europe, we’re pleased to announce that we’re supporting new projects that hope to bring us closer to better treatments to transform the lives of those affected by Parkinson’s.
Date
We’ve awarded Cellestial Health £55,000 to continue exploring networks of brain cells that may hold answers for new treatments for Parkinson’s.
Date
Thanks to our crucial funding, a new drug treatment, created by NRG Therapeutics, is moving forwards.
Date
Results from 3 recent studies show that people from South Asian and Black backgrounds are less likely to receive timely access to Parkinson’s care, support and research opportunities.
Date
Tech Guide, our online platform to help people make informed decisions about technology, has been recognised at the Made with Patient awards.
Date
11 people have received the treatment which aims to boost brain cells’ ability to repair themselves.
Date
A clinical trial for people with a sleep disorder who are at higher risk of developing Parkinson’s has begun in Oxfordshire.
Date
Results from a Parkinson’s UK funded study showed the app could help improve many aspects of mental health. The app is available now and free to download.